Skip to main content

RoxyBond FDA Approval History

FDA Approved: Yes (First approved April 20, 2017)
Brand name: RoxyBond
Generic name: oxycodone hydrochloride
Dosage form: Tablets
Company: Protega Pharmaceuticals LLC
Treatment for: Pain

RoxyBond (oxycodone hydrochloride) is an immediate-release, abuse-deterrent, narcotic analgesic formulation for the management of severe pain.

Development timeline for RoxyBond

DateArticle
Oct 29, 2024Approval Protega Pharmaceuticals Receives FDA Approval for RoxyBond (oxycodone hydrochloride) Immediate-Release 10 mg Tablet with Abuse-Deterrent Technology for Management of Pain
Apr 26, 2017Approval Inspirion Delivery Sciences Receives FDA Approval for RoxyBond (oxycodone hydrochloride) Immediate Release Tablets with Abuse-Deterrent Label Claims

See also

RoxyBond (oxycodone hydrochloride) Consumer information

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer